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Purpose: To investigate the clinical significance of gallbladder (GB) wall thickening frequently 
observed in patients with acute hepatitis A.
Methods: A total of 328 consecutive patients who were diagnosed with acute hepatitis A and 
underwent abdominal ultrasonography were enrolled retrospectively. Patients were divided into 
two groups: GB wall thickening (≥3 mm, group A) and no thickening (group B). Group A was 
subdivided into two subgroups (GB wall thickening of ≥10 mm, group A-1 and ≥3 mm to <10 
mm, group A-2). The laboratory results related to liver function, hospitalization duration, and 
time to normalization of liver function were compared between the groups.
Results: A total of 230 patients showed GB wall thickening (group A). Besides gamma-glutamyl 
transpeptidase and alkaline phosphatase, all laboratory results of group A were significantly 
higher than those of group B (P<0.05). Compared with group B, the hospitalization duration 
and the time to normalization of liver function were significantly longer in group A (P<0.05). 
Group A-1 included 146 patients and group A-2 included 84 patients. No significant differences 
in laboratory results, hospitalization duration, and time to normalization of liver function were 
found between the two subgroups. In the multivariate logistic regression analysis, serum alanine 
transaminase, total bilirubin and albumin levels, and hospitalization duration were significantly 
associated with GB wall thickening in patients with hepatitis A.
Conclusion: The presence of GB wall thickening in patients with acute hepatitis A suggests a 
poorer prognosis irrespective of the degree of GB wall thickening or the degree of liver enzyme 
elevation.
Keywords: Hepatitis A; Liver function tests; Gallbladder; Ultrasonography
Received: November 4, 2014
Revised: December 23, 2014
Accepted: January 16, 2015
Correspondence to:
Jae-Joon Chung, MD, Department 
of Radiology, Gangnam Severance 
Hospital, Yonsei University College of 
Medicine, 211 Eonju-ro, Gangnam-gu, 
Seoul 135-720, Korea
Tel. +82-2-2019-3512
Fax. +82-2-3462-5472
E-mail: jjchung@yuhs.ac
ORIGINAL ARTICLE
This is an Open Access article distributed under the 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in 
any medium, provided the original work is properly 
cited.
Copyright © 2015 Korean Society of 
Ultrasound in Medicine (KSUM)
How to cite this article: 
Ahn JH, Chung JJ, Yu JS, Kim JH, Cho ES, 
Kim DJ. Prognostic value of gallbladder wall 
thickening in patients with acute hepatitis A. 
Ultrasonography. 2015 Apr;34(2):139-143.
Introduction
Tens of millions of hepatitis A virus infections occur each year worldwide [1], and the incidence 
of acute hepatitis A has been rapidly increasing in recent years. Gallbladder (GB) wall thickening 
is frequently observed in patients with acute hepatitis A [2-4]. Maresca et al. [4] identified GB 
abnormalities on ultrasonography (US) in 51% of consecutive patients presenting with acute hepatitis. 
In patients with acute viral hepatitis, thickening of the GB wall may be secondary to the inflammatory 
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process in the adjacent liver. Further, the severity of liver cell necrosis 
appears to influence the degree of GB wall thickening [5]. Several 
reports have established a connection between GB wall thickening 
and laboratory findings [4-6]; however, other investigators have 
found no association between GB wall thickening and laboratory 
findings [7,8]. In this study, we investigate the clinical significance 
of GB wall thickening on US in patients serologically confirmed with 
acute hepatitis A.
Materials and Methods
This retrospective study was approved by the Institutional Review 
Board of our medical institution, with the waiver of informed 
consent. From March 2009 to December 2012, a total of 411 
patients were diagnosed with acute hepatitis A at our institution on 
the basis of the results of hepatitis A virus-specific IgM antibodies 
in the blood and liver function tests, and abdominal US. Patients 
underwent blood tests at the time of admission, and on the same 
day or the next day, abdominal US was performed. Among these 
411 patients, we excluded two patients who had a history of 
cholecystectomy, 76 patients for whom there was no follow-up liver 
function test, and five patients who had gallstones. In total, 328 
consecutive patients (median age, 31.2 years; range, 3 to 53 years) 
were enrolled in the study.
Five radiologists with 5-20 years of experience in abdominal US 
performed US using an IU 22 (Phillips Medical Systems, Bothell, WA, 
USA) with a 1-4-MHz convex transducer and an Acuson Sequoia 
512 (Acuson Corporation, Mountain View, CA, USA) with a 4-MHz 
convex transducer. Intercostal or longitudinal US scans were used 
to evaluate the GB wall thickness. Measurement of the GB wall 
thickness was performed by two abdominal radiologists who were 
unaware of the laboratory information of patients. Each reader 
measured the thickness of the GB wall (body portion of the GB) at a 
workstation (Centricity 2.0, GE Healthcare). Thereafter, the measured 
values obtained from the two readers were averaged, and the mean 
value was used. On the basis of previous studies, we considered 
the GB wall to be thickened in fasting subjects whenever its width 
exceeded 3 mm (Fig. 1) [4]. Patients were divided into the following 
two groups: patients with GB wall thickening (group A) and those 
without GB wall thickening (group B). The laboratory results of the 
patients with GB wall thickening were compared with those of 
patients without GB wall thickening. The tests included aspartate 
aminotransferase (AST), alanine transaminase (ALT), total bilirubin, 
direct bilirubin, albumin, alkaline phosphatase (ALP), and gamma-
glutamyl transpeptidase (γ-GT) levels; prothrombin time (PT); 
hospitalization duration; and time to normalization of liver function.
Additionally, group A was subdivided into the following 
two subgroups (group A-1 and group A-2) for the comparison 
of laboratory results, hospitalization duration, and time to 
normalization of the liver function tests: GB wall thickness of 10 
mm or more (group A-1) and GB wall thickness of less than 10 mm 
(≥3 mm to <10 mm, group A-2). Further, group B was subdivided 
into the following two subgroups (group B-1 and group B-2) for the 
comparison of hospitalization duration and time to normalization of 
liver function tests: patients with AST and ALT levels of 500 IU/L or 
more (group B-1) and patients with AST and ALT levels of less than 
500 IU/L (group B-2). If the AST and ALT values were discordant, the 
higher of the two was used for classification.
We used the Mann-Whitney U test for a comparison of the 
continuous variables, and the data were expressed as median 
values and the interquartile range. The correlations between GB 
wall thickening and the variables were assessed using multivariate 
logistic regression analysis to identify the factors related to the GB 
wall thickening. On multivariate logistic regression analysis, we 
used the continuous variables that show a significant P-value on 
the Mann-Whitney U test. In addition, the variance inflation factor 
of total bilirubin and direct bilirubin is more than 10; therefore, 
we excluded direct bilirubin on the multivariate logistic regression 
analysis. Data were analyzed with statistical software SPSS ver. 13.0 
(SPSS Inc., Chicago, IL, USA), and in all tests, a P-value of less than 
0.05 was considered significant.
Fig. 1. A 24-year-old male with acute hepatitis A. Longitudinal 
sonogram of abdomen shows gallbladder wall thickening of about 
12 mm (arrowheads).
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Results
Among the 328 patients, 230 patients (70.1%) showed GB wall 
thickening on US related to acute hepatitis A. The mean GB wall 
thickness was 8.04±3.96 mm. The mean AST, ALT, total bilirubin, 
direct bilirubin, and prolonged PT in group A were significantly 
higher than those in group B (98 patients, 29.9%). The mean 
albumin level in group A was significantly lower than that in group 
B. However, no significant differences were observed between the 
groups with respect to γ-GT or ALP (Table 1).
The hospitalization duration and time to normalization of liver 
function tests were 5.0 days (4.0-8.0 days) and 38.0 days (21.0-
48.0 days) in group A and 5.0 days (3.0-6.3 days) and 24.5  days 
(15.0-45.5 days) in group B, respectively. Compared with group 
B, the hospitalization duration and time to normalization of liver 
function tests were significantly longer in group A (P<0.05). Among 
the patients with GB wall thickening, 146 patients (63.5%) had a 
GB wall thickness of 10 mm or more, and 84 patients (36.5%) had 
Table 2. Clinical and laboratory findings in patients with GB wall thicknesses of 10 mm or more and in patients with wall thicknesses 
of less than 10 mm (≥3 mm to <10 mm)
Characteristic
GB wall thickness of ≥10 mm 
(group A-1, n=146)
GB wall thickness of ≥3 mm to <10 mm 
(group A-2, n=84)
P-value
Age (yr) 32.0 (28.0-36.0) 31.0 (28.0-34.0) 0.248
Laboratory data
 AST (IU/L) 2,542.0 (1,143.0-4,510.0) 2,096.0 (321.0-4,374.0) 0.131
 ALT (IU/L) 3,346.0 (2,179.0-4,710.0) 2,587.0 (1,104.0-4,497.0) 0.013
 Total bilirubin (mg/dL) 4.0 (2.8-5.8) 3.8 (2.3-6.0) 0.699
 Direct bilirubin (mg/dL) 3.0 (2.1-4.3) 2.9 (1.7-4.4) 0.535
 Albumin (IU/L) 4.0 (3.7-4.2) 4.0 (3.7-4.3) 0.399
 ALP (IU/L) 172.0 (140.0-216.8) 156.0 (131.0-215.5) 0.200
 γ-GT (IU/L) 284.0 (193.0-398.0) 262.5 (194.8-379.5) 0.862
 PT (INR) 1.3 (1.1-1.5) 1.2 (1.0-1.4) 0.011
Hospitalization duration (day) 5.0 (4.0-8.0) 6.0 (5.0-8.0) 0.163
Time to normalization (day) 41.0 (21.0-48.0) 32.0 (23.0-47.0) 0.359
Values are presented as median (range).
GB, gallbladder; AST, aspartate aminotransferase; ALT, alanine transaminase; ALP, alkaline phosphatase; γ-GT, gamma-glutamyl transpeptidase; PT, prothrombin time; INR, 
international normalized ratio. 
Table 1. Clinical and laboratory findings for patients with and without GB wall thickening
Characteristic
Patients with GB wall thickening 
(group A, n=230)
Patients without GB wall thickening 
(group B, n=98)
P-value
Age (yr) 31.0 (3.0-53.0) 30.0 (7.0-45.0) 0.253
Laboratory data
 AST (IU/L) 2,435.0 (918.5-4,383.0) 1,200.5 (241.8-3,137.5) <0.001
 ALT (IU/L) 3,121.5 (1,841.8-4,594.5) 1,656.0 (686.0-3,174.5) <0.001
 Total bilirubin (mg/dL) 4.0 (2.7-6.0) 2.4 (1.3-4.1) <0.001
 Direct bilirubin (mg/dL) 2.9 (1.9-4.3) 1.8 (1.0-3.0) <0.001
 Albumin (IU/L) 4.0 (3.7-4.2) 4.2 (3.9-4.5) <0.001
 ALP (IU/L) 166.5 (134.0-215.8) 165.6 (124.8-226.3) 0.552
 γ-GT (IU/L) 278.0 (193.0-386.0) 269.5 (184.5-437.0) 0.976
 PT (INR) 1.3 (1.1-1.4) 1.1 (1.0-1.3) <0.001
Hospitalization duration (day) 5.0 (4.0-8.0) 5.0 (3.0-6.3) 0.004
Time to normalization (day) 38.0 (21.0-48.0) 24.5 (15.0-45.5) 0.004
Values are presented as median (range).
GB, gallbladder; AST, aspartate aminotransferase; ALT, alanine transaminase; ALP, alkaline phosphatase; γ-GT, gamma-glutamyl transpeptidase; PT, prothrombin time; INR, 
international normalized ratio. 
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a GB wall thickness of less than 10 mm (≥3 mm to <10 mm). The 
mean ALT and prolonged PT in group A-1 were significantly higher 
than those of group A-2. However, no significant differences were 
observed between the two subgroups for other laboratory results, 
hospitalization duration, or time to normalization of liver function 
tests (Table 2).
In the multivariate logistic regression analysis, reduced albumin 
level (odds ratio, 0.275; 95% confidence interval [CI], 0.127 to 
0.598; P=0.001), increased ALT level (odds ratio, 1.001; 95% CI, 
1.000 to 1.001; P=0.002), increased total bilirubin level (odds 
ratio, 1.212; 95% CI, 1.081 to 1.360; P=0.001), and prolonged 
hospitalization duration (odds ratio, 1.133; 95% CI, 1.001 to 1.282; 
P=0.047) were significantly associated with GB wall thickening in 
patients with hepatitis A (Table 3).
Among the 98 patients in group B, 80 (81.6%) patients had AST 
or ALT levels of 500 IU/L or more. The mean hospitalization duration 
of the 80 patients was 5.0 days (3.0-7.0 days) and that of the 
other 18 patients was 4.5 days (2.8-6.0 days), a difference that 
was not significant (P=0.302). The mean time to normalization of 
liver function tests of the 80 patients was 33.0 days (19.3-48.8 
days) and that of the other subgroup was 13.5 days (3.0-19.0 
days) (P<0.001).
Discussion
GB wall thickening can be seen after a meal or after pharmacological 
stimulation, such as with cholecystokinin. Further, thickening of 
the GB wall may be observed in the case of acute and chronic 
cholecystitis, neoplasm, adenomyomatosis, obstructive jaundice, 
ascites, hypoalbuminemia, heart failure, and cirrhosis [4].
Inflammatory changes involving the GB may be observed in 
patients with clinical and laboratory findings of acute hepatitis, 
irrespective of the underlying cause. In the case of viral hepatitis, GB 
wall thickening is the most frequently observed pattern on US [4]. 
Moreover, the frequency of GB wall thickening is greater in patients 
with a viral infection than in patients with other potential causes 
of GB wall thickening [9]. In previous reports, the incidences of GB 
wall thickening in patients with acute hepatitis ranged from 51%-
90% [4,6,7,9,10]. In our study, GB wall thickening was identified in 
70.1% of the patients with acute hepatitis A.
Three hypotheses have been suggested to explain the mechanism 
of GB wall thickening in patients with acute hepatitis. One 
hypothesis is that hepatocyte injury causes temporary decreases in 
bile production and excretion [11-13]. The second hypothesis is 
that there is direct injury to and inflammation of the mucosal and 
muscular layers of the GB caused by hepatitis virus contained in the 
bile fluid [14-16]. The third hypothesis is that hepatocyte necrosis 
causes an inflammatory reaction in the tissues surrounding the liver, 
including the GB wall [2,5].
A direct correlation has also been reported between the levels 
of elevation of serum AST and ALT and GB wall thickening on US 
[2,4-6]. However, other studies have reported that the levels of 
serum AST and ALT are not related to GB wall thickening [7,8]. In 
our study, serum AST and ALT levels were significantly elevated in 
group A as compared to in group B. In addition, the bilirubin levels 
and the PT of group were significantly (P<0.001) higher than those 
of group B, suggesting that the GB may be somehow involved in the 
inflammatory process and that this involvement is closely related 
to the clinical course of acute hepatitis A. In fact, in our study, the 
hospitalization duration and time to normalization of liver function 
tests in group A were significantly longer than those in group B. 
Therefore, the US assessment of GB wall thickening may have 
prognostic value for patients with hepatitis A infection.
In our study, the degree of GB wall thickening was not correlated 
with the laboratory results (except ALT level and PT), hospitalization 
duration, or time to normalization of liver function tests. Further, 
81.6% of the group B patients showed AST and ALT levels of 500 IU/L 
or more; no significant difference was observed in the hospitalization 
duration between patients divided into subgroups according to the 
AST and ALT levels. These findings suggest that neither the degree of 
GB wall thickening nor laboratory results are closely correlated with 
the prognosis in patients with acute hepatitis A.
This study has several limitations because of its retrospective 
design. First, no follow-up US was conducted to assess for the 
recovery of GB wall thickening. Second, laboratory follow-up was 
performed at an outpatient clinic within 15-30 days after discharge; 
therefore, the time to normalization of liver function tests may be 
inaccurate. In addition, we excluded 76 patients for whom there 
were no follow-up liver function tests, and the exclusion of these 
patients may well bias the results of the time to normalization of 
Table 3. Multivariate analysis of associated factors associated 
with GB wall thickening
Variable Odds ratio
95% Confidence 
interval
P-value
AST 1.000 1.000-1.000 0.051
ALT 1.001 1.000-1.001 0.002
Total bilirubin 1.212 1.081-1.360 0.001
Albumin 0.275 0.127-0.598 0.001
PT 2.388 0.594-9.596 0.220
Hospitalization duration 1.133 1.001-1.282 0.047
Time to normalization 0.999 0.981-1.017 0.904
GB, gallbladder; AST, aspartate aminotransferase; ALT, alanine transaminase; PT, 
prothrombin time.
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liver function tests. Third, the measurement of GB wall thickness 
may not have been consistent because many different physicians 
performed the US assessments in this retrospective study. 
In conclusion, the presence of GB wall thickening in patients with 
acute hepatitis A suggests a poorer prognosis irrespective of the 
degree of wall thickening or the degree of liver enzyme elevation.
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